Moderna: Stéphane Bancel honored by NAE
The director is being honored for his contributions to the 'development and manufacture of pharmaceutical products, including the COVID-19 vaccine'.
In the thirteen years since he joined the company, Stéphane Bancel has led Moderna from start-up to global commercial enterprise.
To date, the company has 45 mRNA-based therapeutic and vaccine programs in its pipeline, nine of which are at an advanced stage of development. The laboratory is known as one of the first to have developed one of the most effective vaccines against COVID-19.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction